FOLFOXIRI Plus Panitumumab As First-Line Treatment of RAS Wild-Type Metastatic Colorectal Cancer: The Randomized, Open-Label, Phase II VOLFI Study (AIO KRK0109) - Modest, DP; Martens, UM; Riera-Knorrenschild, J (J Clin Oncol, 2019)
et al.